25 XP   0   0   10

Hainan Poly Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Hainan Poly Pharm Co Ltd together

PenkeI guess you are interested in Hainan Poly Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hainan Poly Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hainan Poly Pharm Co Ltd

I send you an email if I find something interesting about Hainan Poly Pharm Co Ltd.

Quick analysis of Hainan Poly Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Hainan Poly Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.96
Expected worth in 1 year
¥7.57
How sure are you?
89.5%

+ What do you gain per year?

Total Gains per Share
¥0.82
Return On Investment
6.6%

For what price can you sell your share?

Current Price per Share
¥12.35
Expected price per share
¥0 - ¥21.34
How sure are you?
50%

1. Valuation of Hainan Poly Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.35

Intrinsic Value Per Share

¥-10.98 - ¥-12.63

Total Value Per Share

¥-4.02 - ¥-5.67

2. Growth of Hainan Poly Pharm Co Ltd (5 min.)




Is Hainan Poly Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$433.9m$373.4m$37.3m9.1%

How much money is Hainan Poly Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$12.7m$16.6m-$3.8m-30.4%
Net Profit Margin20.9%27.4%--

How much money comes from the company's main activities?

3. Financial Health of Hainan Poly Pharm Co Ltd (5 min.)




What can you expect buying and holding a share of Hainan Poly Pharm Co Ltd? (5 min.)

Welcome investor! Hainan Poly Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Hainan Poly Pharm Co Ltd.

What can you expect buying and holding a share of Hainan Poly Pharm Co Ltd?

First you should know what it really means to hold a share of Hainan Poly Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hainan Poly Pharm Co Ltd is ¥12.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hainan Poly Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hainan Poly Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.96. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hainan Poly Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.3%0.030.2%0.040.3%0.030.3%0.030.3%
Usd Book Value Change Per Share0.040.3%0.020.2%0.020.2%0.050.4%0.050.4%
Usd Dividend Per Share0.020.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.050.4%0.030.2%0.030.2%0.060.5%0.060.5%
Usd Price Per Share3.00-3.22-5.47-6.20-6.20-
Price to Earnings Ratio18.23--5.62-78.44-56.63-56.63-
Price-to-Total Gains Ratio54.84-4.71-285.38-232.66-232.66-
Price to Book Ratio3.12-3.56-6.70-12.37-12.37-
Price-to-Total Gains Ratio54.84-4.71-285.38-232.66-232.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.705535
Number of shares586
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.05
Usd Total Gains Per Share0.030.06
Gains per Quarter (586 shares)16.5133.63
Gains per Year (586 shares)66.03134.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
117495616119125
2339912232237260
35014818848356395
46719725464474530
58424732080593665
610029638696711800
7117345452112830935
81343955181289481070
915044458414410671205
1016749365016011851340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%18.01.00.094.7%18.01.00.094.7%18.01.00.094.7%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.03.00.084.2%16.03.00.084.2%16.03.00.084.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%17.02.00.089.5%17.02.00.089.5%17.02.00.089.5%

Fundamentals of Hainan Poly Pharm Co Ltd

About Hainan Poly Pharm Co Ltd

Hainan Poly Pharm. Co., Ltd. engages in the research and development, production, and sale of pharmaceutical drugs in China and internationally. The company's formulations dosage forms comprise injections, tablets, capsules, dry suspensions/granules, eye drops and ointments, etc. covering various therapeutic areas, including cardiovascular, anti-allergy, antibiotics, gastrointestinal, dermatology, and non-steroid anti-inflammatory (NSAIDs). It offers pharmaceutical preparations and active pharmaceutical ingredients (APIs), other raw materials, excipients, prescription and non-prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was incorporated in 1992 and is headquartered in Haikou, China.

Fundamental data was last updated by Penke on 2024-04-23 07:25:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hainan Poly Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hainan Poly Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 25.9% means that ¥0.26 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 25.9%. The company is making a huge profit. +2
  • The TTM is 20.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ25.9%TTM20.9%+5.0%
TTM20.9%YOY27.4%-6.5%
TTM20.9%5Y30.3%-9.4%
5Y30.3%10Y30.3%0.0%
1.1.2. Return on Assets

Shows how efficient Hainan Poly Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.0% Return on Assets means that Hainan Poly Pharm Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.4%+0.6%
TTM1.4%YOY2.3%-0.9%
TTM1.4%5Y3.2%-1.8%
5Y3.2%10Y3.2%0.0%
1.1.3. Return on Equity

Shows how efficient Hainan Poly Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.3% Return on Equity means Hainan Poly Pharm Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 4.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.3%TTM3.0%+1.2%
TTM3.0%YOY4.4%-1.4%
TTM3.0%5Y5.1%-2.1%
5Y5.1%10Y5.1%0.0%

1.2. Operating Efficiency of Hainan Poly Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hainan Poly Pharm Co Ltd is operating .

  • Measures how much profit Hainan Poly Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM13.6%-13.6%
TTM13.6%YOY34.0%-20.4%
TTM13.6%5Y32.1%-18.5%
5Y32.1%10Y32.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Hainan Poly Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.03 means that the operating costs are ¥1.03 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 1.032. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.188. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.032TTM1.188-0.157
TTM1.188YOY0.920+0.269
TTM1.1885Y0.915+0.274
5Y0.91510Y0.9150.000

1.3. Liquidity of Hainan Poly Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hainan Poly Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.93 means the company has ¥1.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 1.929. The company is able to pay all its short-term debts. +1
  • The TTM is 2.004. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.929TTM2.004-0.074
TTM2.004YOY1.844+0.159
TTM2.0045Y1.927+0.076
5Y1.92710Y1.9270.000
1.3.2. Quick Ratio

Measures if Hainan Poly Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.99 means the company can pay off ¥0.99 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 0.986. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.927. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.986TTM0.927+0.059
TTM0.927YOY0.963-0.036
TTM0.9275Y0.925+0.003
5Y0.92510Y0.9250.000

1.4. Solvency of Hainan Poly Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hainan Poly Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hainan Poly Pharm Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Hainan Poly Pharm Co Ltd assets are financed with 53.0% credit (debt) and the remaining percentage (100% - 53.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 0.530. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.527. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.530TTM0.527+0.003
TTM0.527YOY0.474+0.053
TTM0.5275Y0.399+0.128
5Y0.39910Y0.3990.000
1.4.2. Debt to Equity Ratio

Measures if Hainan Poly Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 112.8% means that company has ¥1.13 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hainan Poly Pharm Co Ltd:

  • The MRQ is 1.128. The company is able to pay all its debts with equity. +1
  • The TTM is 1.113. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.128TTM1.113+0.015
TTM1.113YOY0.904+0.209
TTM1.1135Y0.713+0.400
5Y0.71310Y0.7130.000

2. Market Valuation of Hainan Poly Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hainan Poly Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hainan Poly Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 18.23 means the investor is paying ¥18.23 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hainan Poly Pharm Co Ltd:

  • The EOD is 10.382. Based on the earnings, the company is underpriced. +1
  • The MRQ is 18.233. Based on the earnings, the company is fair priced.
  • The TTM is -5.616. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.382MRQ18.233-7.852
MRQ18.233TTM-5.616+23.849
TTM-5.616YOY78.442-84.058
TTM-5.6165Y56.632-62.248
5Y56.63210Y56.6320.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hainan Poly Pharm Co Ltd:

  • The EOD is -19.199. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -33.719. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.428. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.199MRQ-33.719+14.520
MRQ-33.719TTM-12.428-21.291
TTM-12.428YOY-76.955+64.527
TTM-12.4285Y10.676-23.104
5Y10.67610Y10.6760.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hainan Poly Pharm Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hainan Poly Pharm Co Ltd:

  • The EOD is 1.776. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.118. Based on the equity, the company is fair priced.
  • The TTM is 3.562. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.776MRQ3.118-1.343
MRQ3.118TTM3.562-0.444
TTM3.562YOY6.703-3.140
TTM3.5625Y12.370-8.807
5Y12.37010Y12.3700.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hainan Poly Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2860.152+88%0.143+100%0.366-22%0.366-22%
Book Value Per Share--6.9566.584+6%5.986+16%4.806+45%4.806+45%
Current Ratio--1.9292.004-4%1.844+5%1.927+0%1.927+0%
Debt To Asset Ratio--0.5300.527+1%0.474+12%0.399+33%0.399+33%
Debt To Equity Ratio--1.1281.113+1%0.904+25%0.713+58%0.713+58%
Dividend Per Share--0.1090.052+112%0.066+65%0.050+121%0.050+121%
Eps--0.2970.204+45%0.267+12%0.227+31%0.227+31%
Free Cash Flow Per Share---0.161-0.125-22%-0.481+199%-0.281+75%-0.281+75%
Free Cash Flow To Equity Per Share---0.1610.104-254%-0.220+37%0.023-810%0.023-810%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---12.630--------
Intrinsic Value_10Y_min---10.976--------
Intrinsic Value_1Y_max---1.342--------
Intrinsic Value_1Y_min---1.318--------
Intrinsic Value_3Y_max---3.973--------
Intrinsic Value_3Y_min---3.794--------
Intrinsic Value_5Y_max---6.535--------
Intrinsic Value_5Y_min---6.070--------
Market Cap5579421348.800-76%9798999923.52010548946436.800-7%17889160879.280-45%20282795648.640-52%20282795648.640-52%
Net Profit Margin--0.2590.209+24%0.274-5%0.303-14%0.303-14%
Operating Margin---0.136-100%0.340-100%0.321-100%0.321-100%
Operating Ratio--1.0321.188-13%0.920+12%0.915+13%0.915+13%
Pb Ratio1.776-76%3.1183.562-12%6.703-53%12.370-75%12.370-75%
Pe Ratio10.382-76%18.233-5.616+131%78.442-77%56.632-68%56.632-68%
Price Per Share12.350-76%21.69023.350-7%39.598-45%44.896-52%44.896-52%
Price To Free Cash Flow Ratio-19.199+43%-33.719-12.428-63%-76.955+128%10.676-416%10.676-416%
Price To Total Gains Ratio31.224-76%54.8384.710+1064%285.377-81%232.660-76%232.660-76%
Quick Ratio--0.9860.927+6%0.963+2%0.925+7%0.925+7%
Return On Assets--0.0200.014+40%0.023-12%0.032-38%0.032-38%
Return On Equity--0.0430.030+41%0.044-2%0.051-17%0.051-17%
Total Gains Per Share--0.3960.204+94%0.209+89%0.416-5%0.416-5%
Usd Book Value--433964532.274410796667.001+6%373470372.146+16%299848777.276+45%299848777.276+45%
Usd Book Value Change Per Share--0.0400.021+88%0.020+100%0.051-22%0.051-22%
Usd Book Value Per Share--0.9610.909+6%0.827+16%0.664+45%0.664+45%
Usd Dividend Per Share--0.0150.007+112%0.009+65%0.007+121%0.007+121%
Usd Eps--0.0410.028+45%0.037+12%0.031+31%0.031+31%
Usd Free Cash Flow---10033174.234-7811174.176-22%-30006524.870+199%-17517333.342+75%-17517333.342+75%
Usd Free Cash Flow Per Share---0.022-0.017-22%-0.066+199%-0.039+75%-0.039+75%
Usd Free Cash Flow To Equity Per Share---0.0220.014-254%-0.030+37%0.003-810%0.003-810%
Usd Market Cap770518088.269-76%1353241889.4381456809502.922-7%2470493117.429-45%2801054079.077-52%2801054079.077-52%
Usd Price Per Share1.706-76%2.9953.225-7%5.468-45%6.200-52%6.200-52%
Usd Profit--18554389.64512755326.070+45%16637282.873+12%14174271.386+31%14174271.386+31%
Usd Revenue--71562569.55961726817.983+16%60172836.082+19%49469650.199+45%49469650.199+45%
Usd Total Gains Per Share--0.0550.028+94%0.029+89%0.057-5%0.057-5%
 EOD+3 -5MRQTTM+22 -13YOY+23 -125Y+18 -1710Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Hainan Poly Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.382
Price to Book Ratio (EOD)Between0-11.776
Net Profit Margin (MRQ)Greater than00.259
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.986
Current Ratio (MRQ)Greater than11.929
Debt to Asset Ratio (MRQ)Less than10.530
Debt to Equity Ratio (MRQ)Less than11.128
Return on Equity (MRQ)Greater than0.150.043
Return on Assets (MRQ)Greater than0.050.020
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Hainan Poly Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.179
Ma 20Greater thanMa 5015.929
Ma 50Greater thanMa 10017.768
Ma 100Greater thanMa 20019.363
OpenGreater thanClose12.180
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Tax Provision  3,842-9532,888-1,8121,0766,0077,084-8,606-1,522



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,687,316
Total Liabilities3,544,923
Total Stockholder Equity3,142,393
 As reported
Total Liabilities 3,544,923
Total Stockholder Equity+ 3,142,393
Total Assets = 6,687,316

Assets

Total Assets6,687,316
Total Current Assets2,722,404
Long-term Assets3,964,912
Total Current Assets
Cash And Cash Equivalents 447,577
Net Receivables 1,391,743
Inventory 403,569
Other Current Assets 167,603
Total Current Assets  (as reported)2,722,404
Total Current Assets  (calculated)2,410,492
+/- 311,912
Long-term Assets
Property Plant Equipment 3,228,011
Intangible Assets 670,457
Long-term Assets  (as reported)3,964,912
Long-term Assets  (calculated)3,898,468
+/- 66,444

Liabilities & Shareholders' Equity

Total Current Liabilities1,411,094
Long-term Liabilities2,133,828
Total Stockholder Equity3,142,393
Total Current Liabilities
Short Long Term Debt 361,103
Accounts payable 424,499
Other Current Liabilities 15,062
Total Current Liabilities  (as reported)1,411,094
Total Current Liabilities  (calculated)800,664
+/- 610,430
Long-term Liabilities
Long term Debt 1,900,056
Capital Lease Obligations Min Short Term Debt3,021
Long-term Liabilities  (as reported)2,133,828
Long-term Liabilities  (calculated)1,903,077
+/- 230,751
Total Stockholder Equity
Retained Earnings 1,834,095
Total Stockholder Equity (as reported)3,142,393
Total Stockholder Equity (calculated)1,834,095
+/- 1,308,298
Other
Capital Stock436,353
Common Stock Shares Outstanding 436,353
Net Debt 1,813,582
Net Invested Capital 5,403,552
Net Working Capital 1,311,309
Property Plant and Equipment Gross 3,228,011



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,164,293
1,284,242
1,419,086
1,720,307
1,911,516
2,650,614
2,782,796
3,055,999
3,987,868
4,154,893
4,455,246
4,662,240
4,939,390
5,406,277
5,605,973
5,959,021
6,199,028
6,299,681
6,687,316
6,687,3166,299,6816,199,0285,959,0215,605,9735,406,2774,939,3904,662,2404,455,2464,154,8933,987,8683,055,9992,782,7962,650,6141,911,5161,720,3071,419,0861,284,2421,164,293
   > Total Current Assets 
390,931
373,565
471,956
677,990
630,400
1,188,904
1,260,043
1,232,785
1,707,492
1,874,840
1,871,824
2,025,031
1,960,891
2,136,364
2,211,165
2,443,098
2,410,564
2,353,730
2,722,404
2,722,4042,353,7302,410,5642,443,0982,211,1652,136,3641,960,8912,025,0311,871,8241,874,8401,707,4921,232,7851,260,0431,188,904630,400677,990471,956373,565390,931
       Cash And Cash Equivalents 
65,745
45,702
41,101
198,975
109,973
327,824
246,133
356,657
857,425
738,711
624,768
442,264
470,600
378,220
184,012
777,249
558,388
391,919
447,577
447,577391,919558,388777,249184,012378,220470,600442,264624,768738,711857,425356,657246,133327,824109,973198,97541,10145,70265,745
       Short-term Investments 
0
0
0
0
0
230,000
230,000
550
550
550
550
70,550
550
550
0
456
456
0
0
00456456055055070,550550550550550230,000230,00000000
       Net Receivables 
127,591
172,729
223,961
354,037
352,735
448,728
511,535
689,162
667,714
733,386
875,340
961,274
956,692
1,074,798
1,293,330
1,028,481
1,028,696
1,130,269
1,391,743
1,391,7431,130,2691,028,6961,028,4811,293,3301,074,798956,692961,274875,340733,386667,714689,162511,535448,728352,735354,037223,961172,729127,591
       Inventory 
79,662
104,293
97,552
69,715
113,660
118,425
132,760
94,089
114,188
234,785
281,055
262,171
317,578
377,249
384,257
322,511
485,460
447,524
403,569
403,569447,524485,460322,511384,257377,249317,578262,171281,055234,785114,18894,089132,760118,425113,66069,71597,552104,29379,662
       Other Current Assets 
24,266
20,014
30,250
54,711
54,032
63,926
139,614
92,326
67,615
167,407
90,111
288,771
215,471
305,547
349,567
314,401
337,564
237,088
167,603
167,603237,088337,564314,401349,567305,547215,471288,77190,111167,40767,61592,326139,61463,92654,03254,71130,25020,01424,266
   > Long-term Assets 
773,363
910,677
947,130
1,042,317
1,281,116
1,461,710
1,522,754
1,823,215
2,280,377
2,280,053
2,583,422
2,637,209
2,978,499
3,269,913
3,394,808
3,515,923
3,788,464
3,945,950
3,964,912
3,964,9123,945,9503,788,4643,515,9233,394,8083,269,9132,978,4992,637,2092,583,4222,280,0532,280,3771,823,2151,522,7541,461,7101,281,1161,042,317947,130910,677773,363
       Property Plant Equipment 
721,990
804,262
807,762
897,351
1,135,713
1,291,911
1,354,538
1,559,219
2,018,526
2,017,308
2,315,825
2,208,627
2,636,793
2,819,607
2,924,354
2,900,103
3,122,030
3,205,683
3,228,011
3,228,0113,205,6833,122,0302,900,1032,924,3542,819,6072,636,7932,208,6272,315,8252,017,3082,018,5261,559,2191,354,5381,291,9111,135,713897,351807,762804,262721,990
       Intangible Assets 
36,789
65,153
100,670
112,188
113,093
132,010
131,871
215,470
214,709
215,816
219,044
269,686
297,182
296,424
317,271
554,931
606,173
671,025
670,457
670,457671,025606,173554,931317,271296,424297,182269,686219,044215,816214,709215,470131,871132,010113,093112,188100,67065,15336,789
       Long-term Assets Other 
6,777
6,777
6,777
1,042,317
1,281,116
0
1,354,538
0
0
0
0
102,320
0
104,154
104,154
0
0
0
0
0000104,154104,1540102,32000001,354,53801,281,1161,042,3176,7776,7776,777
> Total Liabilities 
211,916
319,363
368,389
574,365
713,177
866,691
825,566
1,016,848
1,575,024
1,731,106
1,846,700
2,120,484
2,229,658
2,707,384
2,738,965
3,156,510
3,258,533
3,286,552
3,544,923
3,544,9233,286,5523,258,5333,156,5102,738,9652,707,3842,229,6582,120,4841,846,7001,731,1061,575,0241,016,848825,566866,691713,177574,365368,389319,363211,916
   > Total Current Liabilities 
150,401
252,128
308,215
432,850
482,882
639,024
596,623
674,558
659,537
802,896
928,140
1,039,683
1,039,436
1,305,796
1,159,819
1,484,098
1,248,308
938,447
1,411,094
1,411,094938,4471,248,3081,484,0981,159,8191,305,7961,039,4361,039,683928,140802,896659,537674,558596,623639,024482,882432,850308,215252,128150,401
       Short-term Debt 
35,000
79,400
115,210
250,589
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000250,589115,21079,40035,000
       Short Long Term Debt 
35,000
79,400
115,210
250,589
270,911
312,936
340,770
169,774
124,022
167,078
315,651
347,115
466,070
629,615
538,285
613,390
484,842
321,086
361,103
361,103321,086484,842613,390538,285629,615466,070347,115315,651167,078124,022169,774340,770312,936270,911250,589115,21079,40035,000
       Accounts payable 
27,259
118,157
117,457
82,016
123,233
159,150
141,801
279,981
364,796
367,721
399,224
432,974
448,195
417,748
423,704
401,994
408,170
323,034
424,499
424,499323,034408,170401,994423,704417,748448,195432,974399,224367,721364,796279,981141,801159,150123,23382,016117,457118,15727,259
       Other Current Liabilities 
0
0
70,411
48,455
83,908
110,734
106,364
139,886
163,736
191,471
204,421
148,274
116,096
163,445
186,052
209,496
191,578
200,473
15,062
15,062200,473191,578209,496186,052163,445116,096148,274204,421191,471163,736139,886106,364110,73483,90848,45570,41100
   > Long-term Liabilities 
61,515
67,235
60,174
141,515
230,295
227,667
228,943
342,290
915,487
928,210
918,561
1,080,801
1,190,222
1,401,588
1,579,146
1,672,412
2,010,225
2,348,104
2,133,828
2,133,8282,348,1042,010,2251,672,4121,579,1461,401,5881,190,2221,080,801918,561928,210915,487342,290228,943227,667230,295141,51560,17467,23561,515
       Other Liabilities 
42,900
49,535
41,559
76,868
91,370
76,042
90,018
135,482
146,900
134,833
133,389
148,667
130,037
142,404
154,866
186,676
199,569
197,184
0
0197,184199,569186,676154,866142,404130,037148,667133,389134,833146,900135,48290,01876,04291,37076,86841,55949,53542,900
       Deferred Long Term Liability 
8,445
10,624
13,780
28,522
29,922
35,101
36,222
121,219
100,028
104,159
109,492
139,763
143,607
146,767
169,690
359,813
368,736
396,847
0
0396,847368,736359,813169,690146,767143,607139,763109,492104,159100,028121,21936,22235,10129,92228,52213,78010,6248,445
> Total Stockholder Equity
952,377
964,879
1,050,697
1,145,941
1,198,339
1,783,923
1,957,231
2,039,151
2,412,845
2,423,787
2,608,545
2,541,755
2,709,732
2,698,893
2,867,008
2,802,511
2,940,495
3,013,129
3,142,393
3,142,3933,013,1292,940,4952,802,5112,867,0082,698,8932,709,7322,541,7552,608,5452,423,7872,412,8452,039,1511,957,2311,783,9231,198,3391,145,9411,050,697964,879952,377
   Common Stock
183,176
274,765
274,765
274,765
274,765
283,968
436,989
436,989
437,029
437,029
436,980
436,980
436,981
436,958
436,958
436,352
436,352
436,353
0
0436,353436,352436,352436,958436,958436,981436,980436,980437,029437,029436,989436,989283,968274,765274,765274,765274,765183,176
   Retained Earnings 
394,084
406,585
492,404
636,431
688,829
734,460
861,688
983,434
1,126,788
1,126,845
1,292,692
1,318,322
1,480,100
1,522,470
1,690,322
1,655,474
1,793,907
1,891,303
1,834,095
1,834,0951,891,3031,793,9071,655,4741,690,3221,522,4701,480,1001,318,3221,292,6921,126,8451,126,788983,434861,688734,460688,829636,431492,404406,585394,084
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
229,370
229,370
229,370
141,125
141,420
141,647
141,908
120,837
120,388
120,620
0
0120,620120,388120,837141,908141,647141,420141,125229,370229,370229,37000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,787,888
Cost of Revenue-734,394
Gross Profit1,053,4941,053,494
 
Operating Income (+$)
Gross Profit1,053,494
Operating Expense-1,391,480
Operating Income396,408-337,986
 
Operating Expense (+$)
Research Development234,641
Selling General Administrative417,559
Selling And Marketing Expenses-
Operating Expense1,391,480652,200
 
Net Interest Income (+$)
Interest Income4,225
Interest Expense-5,405
Other Finance Cost-937
Net Interest Income-243
 
Pretax Income (+$)
Operating Income396,408
Net Interest Income-243
Other Non-Operating Income Expenses-
Income Before Tax (EBT)378,978396,408
EBIT - interestExpense = -5,405
369,452
374,857
Interest Expense5,405
Earnings Before Interest and Taxes (EBIT)-384,382
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax378,978
Tax Provision-9,526
Net Income From Continuing Ops369,452369,452
Net Income369,452
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-243
 

Technical Analysis of Hainan Poly Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hainan Poly Pharm Co Ltd. The general trend of Hainan Poly Pharm Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hainan Poly Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hainan Poly Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 13.39 < 21.25 < 21.34.

The bearish price targets are: .

Tweet this
Hainan Poly Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hainan Poly Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hainan Poly Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hainan Poly Pharm Co Ltd. The current macd is -1.2150685.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hainan Poly Pharm Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hainan Poly Pharm Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hainan Poly Pharm Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hainan Poly Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHainan Poly Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hainan Poly Pharm Co Ltd. The current adx is 41.70.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hainan Poly Pharm Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Hainan Poly Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hainan Poly Pharm Co Ltd. The current sar is 15.27.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hainan Poly Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hainan Poly Pharm Co Ltd. The current rsi is 23.18. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Hainan Poly Pharm Co Ltd Daily Relative Strength Index (RSI) ChartHainan Poly Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hainan Poly Pharm Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hainan Poly Pharm Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hainan Poly Pharm Co Ltd Daily Stochastic Oscillator ChartHainan Poly Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hainan Poly Pharm Co Ltd. The current cci is -134.30580334.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hainan Poly Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartHainan Poly Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hainan Poly Pharm Co Ltd. The current cmo is -61.43390155.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hainan Poly Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHainan Poly Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hainan Poly Pharm Co Ltd. The current willr is -96.75090253.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hainan Poly Pharm Co Ltd Daily Williams %R ChartHainan Poly Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hainan Poly Pharm Co Ltd.

Hainan Poly Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hainan Poly Pharm Co Ltd. The current atr is 0.888165.

Hainan Poly Pharm Co Ltd Daily Average True Range (ATR) ChartHainan Poly Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hainan Poly Pharm Co Ltd. The current obv is -283,975,518.

Hainan Poly Pharm Co Ltd Daily On-Balance Volume (OBV) ChartHainan Poly Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hainan Poly Pharm Co Ltd. The current mfi is 21.92.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hainan Poly Pharm Co Ltd Daily Money Flow Index (MFI) ChartHainan Poly Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hainan Poly Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Hainan Poly Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hainan Poly Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.179
Ma 20Greater thanMa 5015.929
Ma 50Greater thanMa 10017.768
Ma 100Greater thanMa 20019.363
OpenGreater thanClose12.180
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hainan Poly Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hainan Poly Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hainan Poly Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hainan Poly Pharm Co Ltd

I send you an email if I find something interesting about Hainan Poly Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hainan Poly Pharm Co Ltd.

Receive notifications about Hainan Poly Pharm Co Ltd in your mailbox!